Consistently, in MYC-overexpressing tumor cells, LAT1/LAT3 inhibition compromises metabolic reprogramming and, in particular, the depletion of LAT1 significantly inhibits glucose and Gln uptake [69]. Here, LAT is linked to neoplasm.